| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1994;108:813-822
© 1994 Mosby, Inc.
GENERAL THORACIC SURGERY |
Los Angeles, Calif., and Omaha, Neb.
From the Departments of Surgery a and Pathology, b University of Southern California, Los Angeles, Calif., and the Department of Pathology, c Clarkson Memorial Hospital, Omaha, Neb.
Address for reprints: Tom R. DeMeester, MD, University of Southern California School of Medicine, Department of Surgery, 1510 San Pablo St., Suite 514, Los Angeles, CA 90033-4612.
Abstract
The value of endoscopic surveillance of Barrett's esophagus and the appropriate management of high-grade dysplasia remain unclear. Seventeen patients who were referred from endoscopic surveillance programs for management of high-grade dysplasia or adenocarcinoma developing in Barrett's esophagus were compared with 35 patients who had a newly recognized Barrett's adenocarcinoma, who had not been in a surveillance program. The referral diagnosis in the surveyed group was adenocarcinoma in six and high-grade dysplasia in 11. After repeat endoscopy with aggressive biopsy, two additional patients with adenocarcinoma were identified. Of the nine patients who underwent esophagectomy for high-grade dysplasia, five had invasive adenocarcinoma in the esophagectomy specimen, which had been missed before the operation, despite the fact that the median number of biopsy specimens obtained per 2 cm of Barrett's mucosa was 7.8 (range 1.5 to 15.0). Overall, 13 patients in the surveyed group had adenocarcinoma, 12 staged early and one staged intermediate by the WNM classification. Surveyed patients were operated on at an earlier stage than the nonsurveyed patients (10 early, 14 intermediate, and 11 late stage tumors;
2 = 15.6, p < 0.01). Despite the presence of adenocarcinoma in 13 of the 17 surveyed patients, their survival was significantly better than that of the nonsurveyed group (2 = 5.8, p < 0.05). Patients referred from surveillance programs for Barrett's esophagus have a better outcome and earlier stage tumors than nonsurveyed patients. Inasmuch as multiple biopsy procedures do not exclude the presence of adenocarcinoma, continued surveillance of high-grade dysplasia is dangerous and potentially destructive to surveillance efforts. (J THORAC CARDIOVASC SURG 1994;108:813-22)
This article has been cited by other articles:
|
|
 |
|
  P Lao-Sirieix, A Boussioutas, S R Kadri, M O'Donovan, I Debiram, M Das, L Harihar, and R C Fitzgerald Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic Gut, November 1, 2009; 58(11): 1451 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ruol, C. Castoro, G. Portale, F. Cavallin, V. C. Sileni, M. Cagol, R. Alfieri, L. Corti, C. Boso, G. Zaninotto, et al. Trends in Management and Prognosis for Esophageal Cancer Surgery: Twenty-five Years of Experience at a Single Institution Arch Surg, March 1, 2009; 144(3): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yousef, C. Cardwell, M. M. Cantwell, K. Galway, B. T. Johnston, and L. Murray The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis Am. J. Epidemiol., August 1, 2008; 168(3): 237 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Larghi, P G Lecca, and G Costamagna High-resolution narrow band imaging endoscopy Gut, July 1, 2008; 57(7): 976 - 986. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Rygiel, F. Milano, F. J. ten Kate, A. Schaap, K. K. Wang, M. P. Peppelenbosch, J. J.G.H.M. Bergman, and K. K. Krishnadath Gains and Amplifications of c-myc, EGFR, and 20.q13 Loci in the No Dysplasia-Dysplasia-Adenocarcinoma Sequence of Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1380 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Seewald, T L Ang, and N Soehendra Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer Postgrad. Med. J., June 1, 2007; 83(980): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lao-Sirieix, L. Lovat, and R. C. Fitzgerald Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance Clin. Cancer Res., January 15, 2007; 13(2): 659 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Bampton, A. Schloithe, J. Bull, R. J Fraser, R. T A Padbury, and D. I Watson Improving surveillance for Barrett's oesophagus. BMJ, June 3, 2006; 332(7553): 1320 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Souza and S. J. Spechler Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach CA Cancer J Clin, November 1, 2005; 55(6): 334 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Dellon and N. J. Shaheen Does Screening for Barrett's Esophagus and Adenocarcinoma of the Esophagus Prolong Survival? J. Clin. Oncol., July 10, 2005; 23(20): 4478 - 4482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Portale, J. H. Peters, J. A. Hagen, S. R. DeMeester, T. A. K. Gandamihardja, C. Tharavej, C.-C. Hsieh, and T. R. DeMeester Comparison of the Clinical and Histological Characteristics and Survival of Distal Esophageal-Gastroesophageal Junction Adenocarcinoma in Patients With and Without Barrett Mucosa Arch Surg, June 1, 2005; 140(6): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Reed, G. Tolis Jr, B. H. Edil, J. S. Allan, D. M. Donahue, H. A. Gaissert, A. C. Moncure, J. C. Wain, C. D. Wright, and D. J. Mathisen Surgical Treatment of Esophageal High-Grade Dysplasia Ann. Thorac. Surg., April 1, 2005; 79(4): 1110 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N J Shaheen, J M Inadomi, B F Overholt, and P Sharma What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis Gut, December 1, 2004; 53(12): 1736 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Chang and D. A. Katzka Gastroesophageal Reflux Disease, Barrett Esophagus, and Esophageal Adenocarcinoma Arch Intern Med, July 26, 2004; 164(14): 1482 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Johansson, T. R. DeMeester, J. A. Hagen, S. R. DeMeester, J. H. Peters, S. Oberg, and C. G. Bremner En Bloc vs Transhiatal Esophagectomy for Stage T3 N1 Adenocarcinoma of the Distal Esophagus Arch Surg, June 1, 2004; 139(6): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Sirieix, M. O'Donovan, J. Brown, V. Save, N. Coleman, and R. C. Fitzgerald Surface Expression of Minichromosome Maintenance Proteins Provides a Novel Method for Detecting Patients at Risk for Developing Adenocarcinoma in Barrett's Esophagus Clin. Cancer Res., July 1, 2003; 9(7): 2560 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A M. Fendrick, and N. Vakil Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis Ann Intern Med, February 4, 2003; 138(3): 176 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Egger, M Werner, A Meining, R Ott, H-D Allescher, H Hofler, M Classen, and T Rosch Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques Gut, January 1, 2003; 52(1): 18 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K K Basu and J S de Caestecker Surveillance in Barrett's oesophagus: a personal view Postgrad. Med. J., May 1, 2002; 78(919): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Spechler Barrett's Esophagus N. Engl. J. Med., March 14, 2002; 346(11): 836 - 842. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Klaus and R. A. Hinder Indications for Antireflux Surgery in Barrett's Surgical Innovation, December 1, 2001; 8(4): 234 - 239. [Abstract] [PDF]
|
|
|
|
|
|
G. M. R. Campos, S. R. DeMeester, J. H. Peters, S. Oberg, P. F. Crookes, J. A. Hagen, C. G. Bremner, L. F. Sillin III, R. J. Mason, and T. R. DeMeester Predictive Factors of Barrett Esophagus: Multivariate Analysis of 502 Patients With Gastroesophageal Reflux Disease Arch Surg, November 1, 2001; 136(11): 1267 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hagen and T. R. DeMeester Esophageal adenocarcinoma Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Eads, R. V. Lord, K. Wickramasinghe, T. I. Long, S. K. Kurumboor, L. Bernstein, J. H. Peters, S. R. DeMeester, T. R. DeMeester, K. A. Skinner, et al. Epigenetic Patterns in the Progression of Esophageal Adenocarcinoma Cancer Res., April 1, 2001; 61(8): 3410 - 3418. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C. Galipeau, L. J. Prevo, C. A. Sanchez, G. M. Longton, and B. J. Reid Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue J Natl Cancer Inst, December 15, 1999; 91(24): 2087 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Morales and R. E. Sampliner Barrett's Esophagus: Update on Screening, Surveillance, and Treatment Arch Intern Med, July 12, 1999; 159(13): 1411 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Reed Surgical Management of Esophageal Carcinoma Oncologist, April 1, 1999; 4(2): 95 - 105. [Abstract] [Full Text]
|
|
|
|
|
|
J W van Sandick, J J B van Lanschot, B W Kuiken, G N J Tytgat, G J A Offerhaus, and H Obertop Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut, August 1, 1998; 43(2): 216 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hoff, J. L. Sawyers, C. D. Blanke, H. Choy, and J. R. Stewart Prognosis of Adenocarcinoma Arising in Barrett's Esophagus Ann. Thorac. Surg., January 1, 1998; 65(1): 176 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Ferguson and K. S. Naunheim RESECTION FOR BARRETT'S MUCOSA WITH HIGH-GRADE DYSPLASIA: IMPLICATIONS FOR PROPHYLACTIC PHOTODYNAMIC THERAPY J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 824 - 829. [Abstract] [Full Text]
|
|
|
|
|
|
A. G. Little Barrett's Esophagus Ann. Thorac. Surg., July 1, 1996; 62(1): 315 - 315. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
